Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ventricular assist devices as destination therapy.

Stephen Westaby1

  • 1Department of Cardiac Surgery, Oxford Heart Centre, John Radcliffe Hospital, Headley Way, Headington, Oxford OX3 9DU, UK. swestaby@ahf.org.uk

The Surgical Clinics of North America
|April 1, 2004
PubMed
Summary

Mechanical circulatory support is advancing with axial and centrifugal pumps offering alternatives to traditional devices. These innovations, alongside improved management, enhance outcomes for patients needing left ventricular assist devices (LVADs).

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evolution of a circulatory support system with full implantability: personal perspectives on a long journey.

The British journal of cardiology·2023
Same author

Transcriptomal Insights of Heart Failure from Normality to Recovery.

Biomolecules·2022
Same author

Editorial Expression of Concern: Implantation of a Novel Allogeneic Mesenchymal Precursor Cell Type in Patients with Ischemic Cardiomyopathy Undergoing Coronary Artery Bypass Grafting: an Open Label Phase IIa Trial.

Journal of cardiovascular translational research·2020
Same author

Mechanical assist devices for acute cardiogenic shock.

The Cochrane database of systematic reviews·2020
Same author

Response to the commentary from Bisbal et al., titled 'Adipose graft transposition procedure: towards a novel strategy for myocardial scar and fibrosis reduction'.

European heart journal·2019
Same author

Can we remove scar and fibrosis from adult human myocardium?

European heart journal·2018

Area of Science:

  • Cardiovascular Medicine
  • Biomedical Engineering
  • Medical Devices

Background:

  • Long-term mechanical circulatory support (MCS) is crucial for advanced heart failure.
  • First-generation pulsatile LVADs have limitations.
  • Emerging pump technologies offer potential advantages.

Purpose of the Study:

  • To review the current state and future prospects of MCS.
  • To compare different types of ventricular assist devices (VADs).
  • To highlight the importance of patient selection and management in VAD therapy.

Main Methods:

  • Review of existing clinical data and technological advancements in MCS.
  • Comparison of axial flow, pulsatile, and centrifugal pumps.
  • Analysis of outcomes related to diminished pulse pressure and mechanical unloading.

Related Experiment Videos

Main Results:

  • Axial flow pumps are viable alternatives to pulsatile LVADs, potentially serving different patient groups.
  • Centrifugal pumps are under development and may require less anticoagulation.
  • Mechanical unloading can promote native left ventricle recovery, making assist preferable to replacement.
  • Diminished pulse pressure circulation is clinically safe.

Conclusions:

  • Left ventricular assist is often preferable to ventricular replacement.
  • Optimized medical management significantly improves patient outcomes.
  • Further clinical trials for destination therapy are needed, focusing on reliable blood pumps implanted before end-stage organ decline.